Kras mutation is a marker of worse oncologic outcomes after percutaneous radiofrequency ablation of colorectal liver metastases

BACKGROUND: Kras mutation has been associated with shorter overall survival and time to disease recurrence after resection of colorectal liver metastases (CLM). This study evaluated the prognostic value of Kras mutation in patients with CLM treated by percutaneous radiofrequency ablation (RFA). METH...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncotarget
Autori principali: Shady, Waleed, Petre, Elena N., Vakiani, Efsevia, Ziv, Etay, Gonen, Mithat, Brown, Karen T., Kemeny, Nancy E., Solomon, Stephen B., Solit, David B., Sofocleous, Constantinos T.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Impact Journals LLC 2017
Soggetti:
Research Paper
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5630397/
https://ncbi.nlm.nih.gov/pubmed/29029497
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.19806
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi